2Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis [J]. Minerva Anestesiol, 2006, 72 (1/2): 69 -80.
3Kushimoto S, Shibata Y, Koido Y, et al. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy [J]. Nihon Med Sch, 2007, 74 (3) : 236-240.
4Lee CC, Chen SY, Tsai CL, et al. Prognostie value of mortality in emergency department sepsis score, procaleitonin, and C-reactive protein in patients with sepsis at the emergency department [ J ]. Shock, 2008, 29 (3) : 322-327.
5Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Crit Care Med, 2003, 31 (4) : 1250-1256.
6Christ-Crain M, Jaccard Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infection trial [ J ]. Lancet, 2004, 363 (9409) : 600-607.
7Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Chest, 1992, 101 (3): 1644-1655.
8Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin [J]. Physiol Res, 2000, 49 Suppl 1: S57-61.
9Indino P, Lemarchand P, Bady P, et al. Prospective study on procalcitonin and other systemic infection markers in patients with lenkocytosis [J]. Int J Infect Dis, 2008, 12: 319-324.
10Becket KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target [J]. Br J Pharmacol, 2010, 159 (2) : 253-264.
